_version_ 1784831256046862336
author Calimeri, Teresa
Steffanoni, Sara
Laurenge, Alice
Fox, Christopher P.
Soussain, Carole
Grommes, Christian
Tisi, Maria Chiara
Boot, Jesca
Crosbie, Nicola
Visco, Carlo
Arcaini, Luca
Chaganti, Sridhar
Alencar, Alvaro J.
Armiento, Daniele
Romano, Ilaria
Sassone, Marianna C.
Dietrich, Jorg
Itchaki, Gilad
Bruna, Riccardo
Fracchiolla, Nicola S
Arletti, Laura
Venditti, Adriano
Booth, Stephen
Musto, Pellegrino
Hoang-Xuan, Khe
Batchelor, Tracy
Cwynarski, Kate
Ferreri, Andrés J.M.
author_facet Calimeri, Teresa
Steffanoni, Sara
Laurenge, Alice
Fox, Christopher P.
Soussain, Carole
Grommes, Christian
Tisi, Maria Chiara
Boot, Jesca
Crosbie, Nicola
Visco, Carlo
Arcaini, Luca
Chaganti, Sridhar
Alencar, Alvaro J.
Armiento, Daniele
Romano, Ilaria
Sassone, Marianna C.
Dietrich, Jorg
Itchaki, Gilad
Bruna, Riccardo
Fracchiolla, Nicola S
Arletti, Laura
Venditti, Adriano
Booth, Stephen
Musto, Pellegrino
Hoang-Xuan, Khe
Batchelor, Tracy
Cwynarski, Kate
Ferreri, Andrés J.M.
author_sort Calimeri, Teresa
collection PubMed
description
format Online
Article
Text
id pubmed-9665276
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652762022-11-16 Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group Calimeri, Teresa Steffanoni, Sara Laurenge, Alice Fox, Christopher P. Soussain, Carole Grommes, Christian Tisi, Maria Chiara Boot, Jesca Crosbie, Nicola Visco, Carlo Arcaini, Luca Chaganti, Sridhar Alencar, Alvaro J. Armiento, Daniele Romano, Ilaria Sassone, Marianna C. Dietrich, Jorg Itchaki, Gilad Bruna, Riccardo Fracchiolla, Nicola S Arletti, Laura Venditti, Adriano Booth, Stephen Musto, Pellegrino Hoang-Xuan, Khe Batchelor, Tracy Cwynarski, Kate Ferreri, Andrés J.M. Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665276/ http://dx.doi.org/10.1182/blood-2022-167915 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Abstracts
Calimeri, Teresa
Steffanoni, Sara
Laurenge, Alice
Fox, Christopher P.
Soussain, Carole
Grommes, Christian
Tisi, Maria Chiara
Boot, Jesca
Crosbie, Nicola
Visco, Carlo
Arcaini, Luca
Chaganti, Sridhar
Alencar, Alvaro J.
Armiento, Daniele
Romano, Ilaria
Sassone, Marianna C.
Dietrich, Jorg
Itchaki, Gilad
Bruna, Riccardo
Fracchiolla, Nicola S
Arletti, Laura
Venditti, Adriano
Booth, Stephen
Musto, Pellegrino
Hoang-Xuan, Khe
Batchelor, Tracy
Cwynarski, Kate
Ferreri, Andrés J.M.
Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group
title Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group
title_full Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group
title_fullStr Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group
title_full_unstemmed Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group
title_short Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group
title_sort impact on tumour treatment and outcome of sars-cov-2 infection in 91 patients with primary cns lymphoma: a real-life study of the international pcnsl collaborative group
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665276/
http://dx.doi.org/10.1182/blood-2022-167915
work_keys_str_mv AT calimeriteresa impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT steffanonisara impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT laurengealice impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT foxchristopherp impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT soussaincarole impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT grommeschristian impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT tisimariachiara impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT bootjesca impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT crosbienicola impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT viscocarlo impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT arcainiluca impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT chagantisridhar impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT alencaralvaroj impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT armientodaniele impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT romanoilaria impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT sassonemariannac impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT dietrichjorg impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT itchakigilad impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT brunariccardo impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT fracchiollanicolas impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT arlettilaura impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT vendittiadriano impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT boothstephen impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT mustopellegrino impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT hoangxuankhe impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT batchelortracy impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT cwynarskikate impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup
AT ferreriandresjm impactontumourtreatmentandoutcomeofsarscov2infectionin91patientswithprimarycnslymphomaareallifestudyoftheinternationalpcnslcollaborativegroup